Anju Bhardwaj, MD
See Publications

Texas Heart Institute Positions

  • Fellow , Cardiovascular Disease Fellowship
  • Fellow, Advanced Heart Failure Fellowship

Education

  • Medical School:

    Government Medical College (India)

  • Residency:

    St. Joseph Regional Medical Center (Patterson, NJ)

Publications

4862227 G9NNXTPP 1 alternatives-to-animal-experimentation 10 date desc Bhardwaj 1827 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%222NY35K7D%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gaggin%20et%20al.%22%2C%22parsedDate%22%3A%222017-01-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGaggin%2C%20H.%20K.%2C%20Liu%2C%20Y.%2C%20Lyass%2C%20A.%20et%20al.%20%282017%29.%20Incident%20type%202%20myocardial%20infarction%20in%20a%20cohort%20of%20patients%20undergoing%20coronary%20or%20peripheral%20arterial%20angiography.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B135%26lt%3B%5C%2Fi%26gt%3B%2C%20116%26%23x2013%3B127.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.116.023052%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.116.023052%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Incident%20type%202%20myocardial%20infarction%20in%20a%20cohort%20of%20patients%20undergoing%20coronary%20or%20peripheral%20arterial%20angiography%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%20K.%22%2C%22lastName%22%3A%22Gaggin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuyin%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asya%22%2C%22lastName%22%3A%22Lyass%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%20R.%20J.%22%2C%22lastName%22%3A%22van%20Kimmenade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shweta%20R.%22%2C%22lastName%22%3A%22Motiwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noreen%20P.%22%2C%22lastName%22%3A%22Kelly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aditi%22%2C%22lastName%22%3A%22Mallick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parul%20U.%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nasrien%20E.%22%2C%22lastName%22%3A%22Ibrahim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mandy%20L.%22%2C%22lastName%22%3A%22Simon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%20M.%22%2C%22lastName%22%3A%22Belcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%20E.%22%2C%22lastName%22%3A%22Harisiades%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Massaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%20B.%22%2C%22lastName%22%3A%22D%27Agostino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20L.%22%2C%22lastName%22%3A%22Januzzi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Despite%20growing%20recognition%20of%20type%202%20myocardial%20infarction%20%28T2MI%3B%20related%20to%20supply%5C%2Fdemand%20mismatch%29%2C%20little%20is%20known%20about%20its%20risk%20factors%20or%20its%20association%20with%20outcome.%5CnMETHODS%3A%20A%20single-center%20cohort%20of%20patients%20undergoing%20coronary%20or%20peripheral%20angiography%20with%20or%20without%20intervention%20was%20prospectively%20enrolled%20and%20followed%20for%20incident%20type%201%20and%20T2MI%2C%20and%20major%20adverse%20cardiovascular%20events%20%28MACE%2C%20a%20composite%20of%20all-cause%20death%2C%20nonfatal%20myocardial%20infarction%20%5BMI%5D%2C%20heart%20failure%2C%20stroke%2C%20transient%20ischemic%20attack%2C%20peripheral%20arterial%20complication%2C%20and%20cardiac%20arrhythmia%29%2C%20as%20well.%20T2MI%20was%20adjudicated%20using%20criteria%20from%20the%20Third%20Universal%20Definition%20of%20MI.%20Baseline%20characteristics%2C%20blood%20samples%2C%20and%20angiography%20information%20were%20obtained.%20Major%20end%20points%20subsequent%20to%20first%20MI%20were%20assessed%20using%20landmark%20analyses%20to%20compare%20the%20rates%20of%20first%20events%20only%20where%20everyone%20with%20a%20prior%20history%20of%20any%20MACE%20before%20MI%20were%20censored%20and%20adjusted%20for%20follow-up%20times.%20Cox%20proportional%20hazard%20models%20were%20used%20for%20time-to-event%20analyses%20with%20age%20and%20sex%20forced%20into%20all%20models%20and%20additional%20covariates%20evaluated%20by%20using%20the%20stepwise%20option%20for%20the%20selection.%5CnRESULTS%3A%20One%20thousand%20two%20hundred%20fifty-one%20patients%20were%20enrolled%20and%20followed%20for%20a%20median%20of%203.4%20years.%20Of%20these%20patients%2C%20152%20%2812.2%25%29%20had%20T2MI%20during%20follow-up%3B%20T2MI%20was%20frequently%20recurrent.%20Multivariable%20predictors%20of%20T2MI%20were%20older%20age%2C%20lower%20systolic%20blood%20pressure%2C%20history%20of%20coronary%20artery%20disease%2C%20heart%20failure%2C%20chronic%20obstructive%20pulmonary%20disease%2C%20diabetes%20mellitus%2C%20nitrate%20use%2C%20and%20elevated%20concentrations%20of%20glucose%2C%20N-terminal%20pro-B%20type%20natriuretic%20peptide%2C%20and%20cystatin%20C.%20Patients%20with%20T2MI%20had%20higher%20rates%20of%20subsequent%20adverse%20events%20than%20those%20without%20T2MI%20%28per%20100%20person-years%3A%20MACE%2C%2053.7%20versus%2021.1%2C%20P%26lt%3B0.001%3B%20all-cause%20death%2C%2023.3%20versus%203.3%2C%20P%26lt%3B0.001%3B%20cardiovascular%20death%2C%2017.5%20versus%202.6%2C%20P%26lt%3B0.001%3B%20heart%20failure%20events%2C%2022.4%20versus%207.4%2C%20P%26lt%3B0.001%29%3B%20these%20rates%20are%20similar%20to%20those%20seen%20in%20patients%20with%20type%201%20MI.%20Incident%20diagnosis%20of%20T2MI%20strongly%20predicted%20risk%20for%20subsequent%20MACE%20%28adjusted%20hazard%20ratio%2C%201.90%3B%2095%25%20confidence%20interval%2C%201.46-2.48%3B%20P%26lt%3B0.001%29%2C%20all-cause%20death%20%28adjusted%20hazard%20ratio%2C%202.96%3B%2095%25%20confidence%20interval%2C%202.01-4.36%3B%20P%26lt%3B0.001%29%2C%20and%20cardiovascular%20death%20%28adjusted%20hazard%20ratio%2C%202.16%3B%2095%25%20confidence%20interval%2C%201.36-3.43%3B%20P%3D0.001%29.%5CnCONCLUSIONS%3A%20T2MI%20is%20common%20and%20associated%20with%20poor%20prognosis.%20Studies%20evaluating%20treatment%20strategies%20for%20management%20of%20T2MI%20are%20needed.%5CnCLINICAL%20TRIAL%20REGISTRATION%3A%20URL%3A%20http%3A%5C%2F%5C%2Fwww.clinicaltrials.gov.%20Unique%20identifier%3A%20NCT00842868.%22%2C%22date%22%3A%22Jan%2010%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCULATIONAHA.116.023052%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A41%3A11Z%22%7D%7D%2C%7B%22key%22%3A%223UHYHICN%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Malik%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMalik%2C%20S.%2C%20MetroHealth%20Hospital%2C%20Case%20Western%20Reserve%20University%2C%20Cleveland%2C%20OH%2C%20%26lt%3Bstrong%26gt%3BBhardwaj%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20et%20al.%20%282016%29.%20Advanced%20management%20options%20for%20massive%20and%20submassive%20pulmonary%20embolism.%20%26lt%3Bi%26gt%3BUS%20Cardiology%20Review%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%2030.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15420%5C%2Fusc.2016.10.1.30%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15420%5C%2Fusc.2016.10.1.30%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Advanced%20management%20options%20for%20massive%20and%20submassive%20pulmonary%20embolism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonika%22%2C%22lastName%22%3A%22Malik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22MetroHealth%20Hospital%2C%20Case%20Western%20Reserve%20University%2C%20Cleveland%2C%20OH%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22MetroHealth%20Hospital%2C%20Case%20Western%20Reserve%20University%2C%20Cleveland%2C%20OH%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Eisen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22MetroHealth%20Hospital%2C%20Case%20Western%20Reserve%20University%2C%20Cleveland%2C%20OH%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22MetroHealth%20Hospital%2C%20Case%20Western%20Reserve%20University%2C%20Cleveland%2C%20OH%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.15420%5C%2Fusc.2016.10.1.30%22%2C%22ISSN%22%3A%221758-3896%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.radcliffecardiology.com%5C%2Farticles%5C%2Fadvanced-management-options-massive-and-submassive-pulmonary-embolism%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A41%3A26Z%22%7D%7D%2C%7B%22key%22%3A%226NNB6XH3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dunlap%20et%20al.%22%2C%22parsedDate%22%3A%222015-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDunlap%2C%20M.%20E.%2C%20%26lt%3Bstrong%26gt%3BBhardwaj%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20and%20Hauptman%2C%20P.%20J.%20%282015%29.%20Autonomic%20modulation%20in%20heart%20failure%3A%20ready%20for%20prime%20time%3F%20%26lt%3Bi%26gt%3BCurr%20Cardiol%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B%2C%20103.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11886-015-0652-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11886-015-0652-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Autonomic%20modulation%20in%20heart%20failure%3A%20ready%20for%20prime%20time%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20E.%22%2C%22lastName%22%3A%22Dunlap%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Hauptman%22%7D%5D%2C%22abstractNote%22%3A%22It%20has%20been%20known%20for%20many%20decades%20that%20multiple%20abnormalities%20of%20the%20autonomic%20nervous%20system%20%28ANS%29%20are%20present%20in%20heart%20failure%20%28HF%29.%20Moreover%2C%20many%20of%20the%20effective%20therapies%20currently%20used%20to%20treat%20HF%20have%20either%20direct%20or%20indirect%20effects%20on%20the%20ANS.%20While%20therapies%20that%20block%20over-activity%20of%20the%20sympathetic%20nervous%20system%20are%20now%20standard%20of%20care%2C%20much%20less%20well%20studied%20are%20therapies%20aimed%20at%20augmenting%20the%20parasympathetic%20nervous%20system.%20This%20review%20will%20cover%20recent%20and%20ongoing%20investigations%20targeting%20modulation%20of%20the%20ANS%2C%20especially%20highlighting%20new%20and%20ongoing%20studies%20directed%20toward%20augmenting%20parasympathetic%20mechanisms.%22%2C%22date%22%3A%22Nov%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11886-015-0652-2%22%2C%22ISSN%22%3A%221534-3170%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A41%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22RGI8DV76%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22De%20Berardinis%20et%20al.%22%2C%22parsedDate%22%3A%222015-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDe%20Berardinis%2C%20B.%2C%20Gaggin%2C%20H.%20K.%2C%20Magrini%2C%20L.%20et%20al.%20%282015%29.%20Comparison%20between%20admission%20natriuretic%20peptides%2C%20NGAL%20and%20sST2%20testing%20for%20the%20prediction%20of%20worsening%20renal%20function%20in%20patients%20with%20acutely%20decompensated%20heart%20failure.%20%26lt%3Bi%26gt%3BClin%20Chem%20Lab%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B53%26lt%3B%5C%2Fi%26gt%3B%2C%20613%26%23x2013%3B621.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1515%5C%2Fcclm-2014-0191%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1515%5C%2Fcclm-2014-0191%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20between%20admission%20natriuretic%20peptides%2C%20NGAL%20and%20sST2%20testing%20for%20the%20prediction%20of%20worsening%20renal%20function%20in%20patients%20with%20acutely%20decompensated%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedetta%22%2C%22lastName%22%3A%22De%20Berardinis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%20K.%22%2C%22lastName%22%3A%22Gaggin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Magrini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%22%2C%22lastName%22%3A%22Belcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedetta%22%2C%22lastName%22%3A%22Zancla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Femia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mandy%22%2C%22lastName%22%3A%22Simon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shweta%22%2C%22lastName%22%3A%22Motiwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Blair%20A.%22%2C%22lastName%22%3A%22Parry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20T.%22%2C%22lastName%22%3A%22Nagurney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Coudriou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Legrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malha%22%2C%22lastName%22%3A%22Sadoune%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Di%20Somma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20L.%22%2C%22lastName%22%3A%22Januzzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Global%20Research%20on%20Acute%20Conditions%20Team%20%28GREAT%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%20order%20to%20predict%20the%20occurrence%20of%20worsening%20renal%20function%20%28WRF%29%20and%20of%20WRF%20plus%20in-hospital%20death%2C%20101%20emergency%20department%20%28ED%29%20patients%20with%20acute%20decompensated%20heart%20failure%20%28ADHF%29%20were%20evaluated%20with%20testing%20for%20amino-terminal%20pro-B-type%20natriuretic%20peptide%20%28NT-proBNP%29%2C%20BNP%2C%20sST2%2C%20and%20neutrophil%20gelatinase%20associated%20lipocalin%20%28NGAL%29.%5CnMETHODS%3A%20In%20a%20prospective%20international%20study%2C%20biomarkers%20were%20collected%20at%20the%20time%20of%20admission%3B%20the%20occurrence%20of%20subsequent%20in%20hospital%20WRF%20was%20evaluated.%5CnRESULTS%3A%20In%20total%2026%25%20of%20patients%20developed%20WRF.%20Compared%20to%20patients%20without%20WRF%2C%20those%20with%20WRF%20had%20a%20longer%20in-hospital%20length%20of%20stay%20%28LOS%29%20%28mean%20LOS%2013.1%5Cu00b113.4%20days%20vs.%204.8%5Cu00b13.7%20days%2C%20p%26lt%3B0.001%29%20and%20higher%20in-hospital%20mortality%20%5B6%5C%2F26%20%2823%25%29%20vs.%202%5C%2F75%20%282.6%25%29%2C%20p%26lt%3B0.001%5D.%20Among%20the%20biomarkers%20assessed%2C%20baseline%20NT-proBNP%20%284846%20vs.%203024%20pg%5C%2FmL%3B%20p%3D0.04%29%2C%20BNP%20%28609%20vs.%20435%20pg%5C%2FmL%3B%20p%3D0.05%29%20and%20NGAL%20%28234%20vs.%20174%20pg%5C%2FmL%3B%20p%3D0.05%29%20were%20each%20higher%20in%20those%20who%20developed%20WRF.%20In%20logistic%20regression%2C%20the%20combination%20of%20elevated%20natriuretic%20peptide%20and%20NGAL%20were%20additively%20predictive%20for%20WRF%20%28ORNT-proBNP%2BNGAL%3D2.79%3B%20ORBNP%2BNGAL%3D3.11%3B%20both%20p%26lt%3B0.04%29.%20Rates%20of%20WRF%20were%20considerably%20higher%20in%20patients%20with%20elevation%20of%20both%20classes%20of%20biomarker.%20Comparable%20results%20were%20observed%20in%20a%20separate%20cohort%20of%20162%20patients%20with%20ADHF%20from%20a%20different%20center.%5CnCONCLUSIONS%3A%20In%20ED%20patients%20with%20ADHF%2C%20the%20combination%20of%20NT-proBNP%20or%20BNP%20plus%20NGAL%20at%20presentation%20may%20be%20useful%20to%20predict%20impending%20WRF%20%28Clinicaltrials.gov%20NCT%230150153%29.%22%2C%22date%22%3A%22Mar%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1515%5C%2Fcclm-2014-0191%22%2C%22ISSN%22%3A%221437-4331%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22TECXUJM8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bhardwaj%20and%20Dunlap%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BBhardwaj%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20and%20Dunlap%2C%20M.%20E.%20%282015%29.%20Autonomic%20dysregulation%20as%20a%20therapeutic%20target%20for%20acute%20HF.%20%26lt%3Bi%26gt%3BCurr%20Treat%20Options%20Cardiovasc%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11936-015-0403-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11936-015-0403-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Autonomic%20dysregulation%20as%20a%20therapeutic%20target%20for%20acute%20HF%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20E.%22%2C%22lastName%22%3A%22Dunlap%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2210%5C%2F2015%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11936-015-0403-0%22%2C%22ISSN%22%3A%221092-8464%2C%201534-3189%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2Fs11936-015-0403-0%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222020-10-07T22%3A40%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22K6XGNDT4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Athappan%20et%20al.%22%2C%22parsedDate%22%3A%222014-05-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAthappan%2C%20G.%2C%20Gajulapalli%2C%20R.%20D.%2C%20Sengodan%2C%20P.%20et%20al.%20%282014%29.%20Influence%20of%20transcatheter%20aortic%20valve%20replacement%20strategy%20and%20valve%20design%20on%20stroke%20after%20transcatheter%20aortic%20valve%20replacement%3A%20a%20meta-analysis%20and%20systematic%20review%20of%20literature.%20%26lt%3Bi%26gt%3BJ%20Am%20Coll%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%202101%26%23x2013%3B2110.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2014.02.540%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2014.02.540%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Influence%20of%20transcatheter%20aortic%20valve%20replacement%20strategy%20and%20valve%20design%20on%20stroke%20after%20transcatheter%20aortic%20valve%20replacement%3A%20a%20meta-analysis%20and%20systematic%20review%20of%20literature%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ganesh%22%2C%22lastName%22%3A%22Athappan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Dilip%22%2C%22lastName%22%3A%22Gajulapalli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prasanna%22%2C%22lastName%22%3A%22Sengodan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20G.%22%2C%22lastName%22%3A%22Ellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lars%22%2C%22lastName%22%3A%22Svensson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emin%20Murat%22%2C%22lastName%22%3A%22Tuzcu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%20R.%22%2C%22lastName%22%3A%22Kapadia%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20The%20study%20undertook%20a%20systematic%20review%20to%20establish%20and%20compare%20the%20risk%20of%20stroke%20between%20the%202%20widely%20used%20approaches%20%28transfemoral%20%5BTF%5D%20vs.%20transapical%20%5BTA%5D%29%20and%20valve%20designs%20%28CoreValve%2C%20Medtronic%2C%20Minneapolis%2C%20Minnesota%20vs.%20Edwards%20Valve%2C%20Edwards%20Lifesciences%2C%20Irvine%2C%20California%29%20for%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29.%5CnBACKGROUND%3A%20There%20has%20been%20a%20rapid%20adoption%20and%20expansion%20in%20the%20use%20of%20TAVR.%20The%20technique%20is%20however%20far%20from%20perfect%20and%20requires%20further%20refinement%20to%20alleviate%20safety%20concerns%20that%20include%20stroke.%5CnMETHODS%3A%20All%20studies%20reporting%20on%20the%20risk%20of%20stroke%20after%20TAVR%20were%20identified%20using%20an%20electronic%20search%20and%20pooled%20using%20established%20meta-analytical%20guidelines.%5CnRESULTS%3A%2025%20multicenter%20registries%20and%2033%20single-center%20studies%20were%20included%20in%20the%20analysis.%20There%20was%20no%20difference%20in%20pooled%2030-day%20stroke%20post-TAVR%20between%20the%20TF%20and%20TA%20approach%20in%20multicenter%20%282.8%25%20%5B95%25%20confidence%20interval%20%28CI%29%3A%202.4%20to%203.4%5D%20vs.%202.8%25%20%5B95%25%20CI%3A%202.0%20to%203.9%5D%29%20and%20single-center%20studies%20%283.8%25%20%5B95%25%20CI%3A%203.1%20to%204.6%5D%20vs.%203.4%25%20%5B95%25%20CI%3A%202.5%20to%204.5%5D%29.%20Similarly%2C%20there%20was%20no%20difference%20in%20pooled%2030-day%20stroke%20post%20TAVR%20between%20the%20CoreValve%20and%20Edwards%20Valve%20in%20multicenter%20%282.4%25%20%5B95%25%20CI%3A%201.9%20to%203.2%5D%20vs.%203.0%25%20%5B95%25%20CI%3A%202.4%20to%203.7%5D%29%20and%20single-center%20studies%20%283.8%25%20%5B95%25%20CI%3A%202.8%20to%204.9%5D%20vs.%203.2%25%20%5B95%25%20CI%3A%202.4%20to%204.3%5D%29.%20There%20was%20a%20decline%20in%20stroke%20risk%20with%20experience%20and%20technological%20advancement.%20There%20was%20no%20difference%20in%20the%20outcome%20of%2030-day%20stroke%20between%20TAVR%20and%20surgical%20aortic%20valve%20replacement.%5CnCONCLUSIONS%3A%20Our%20findings%20suggest%20that%20the%20risk%20of%2030-day%20stroke%20after%20TAVR%20is%20similar%20between%20the%20approaches%20and%20valve%20types.%20There%20has%20been%20a%20decline%20in%20stroke%20risk%20after%20TAVR%20with%20improvements%20in%20valve%20technology%2C%20patient%20selection%2C%20and%20operator%20experience.%22%2C%22date%22%3A%22May%2027%2C%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacc.2014.02.540%22%2C%22ISSN%22%3A%221558-3597%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22S3UC3CQJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Motiwala%20et%20al.%22%2C%22parsedDate%22%3A%222014-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMotiwala%2C%20S.%20R.%2C%20Szymonifka%2C%20J.%2C%20Belcher%2C%20A.%20et%20al.%20%282014%29.%20Measurement%20of%20novel%20biomarkers%20to%20predict%20chronic%20heart%20failure%20outcomes%20and%20left%20ventricular%20remodeling.%20%26lt%3Bi%26gt%3BJ%20Cardiovasc%20Transl%20Res%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%20250%26%23x2013%3B261.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12265-013-9522-8%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12265-013-9522-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Measurement%20of%20novel%20biomarkers%20to%20predict%20chronic%20heart%20failure%20outcomes%20and%20left%20ventricular%20remodeling%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shweta%20R.%22%2C%22lastName%22%3A%22Motiwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jackie%22%2C%22lastName%22%3A%22Szymonifka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%22%2C%22lastName%22%3A%22Belcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rory%20B.%22%2C%22lastName%22%3A%22Weiner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20L.%22%2C%22lastName%22%3A%22Baggish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%20K.%22%2C%22lastName%22%3A%22Gaggin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20L.%22%2C%22lastName%22%3A%22Januzzi%22%7D%5D%2C%22abstractNote%22%3A%22Myocardial%20remodeling%20is%20pivotal%20in%20the%20progression%20and%20complication%20of%20chronic%20heart%20failure%20%28HF%29.%20We%20assessed%20serial%20measurement%20of%20five%20biomarkers%20with%20biologic%20links%20to%20remodeling%20%28biglycan%2C%20secreted%20frizzled-related%20protein%203%2C%20endostatin%2C%20insulin-like%20growth%20factor%20binding%20protein%207%20%5BIGFBP7%5D%2C%20mimecan%29%20in%20142%20patients%20with%20HF%20followed%20through%20882%20office%20visits.%20IGFBP7%20and%20mimecan%20were%20most%20associated%20with%20events%3B%20in%20fully%20adjusted%20models%2C%20lower%20IGFBP7%20concentrations%20across%20visits%20independently%20predicted%20fewer%20events%20%28odds%20ratio%20%5BOR%5D%5Cu2009%3D%200.83%3B%2095%20%25%20confidence%20interval%20%5BCI%5D%5Cu2009%3D%200.73-0.95%2C%20p%20%3D%200.01%29.%20Subjects%20with%20rising%20mimecan%20had%20greater%20decrease%20in%20left%20ventricular%20end%20diastolic%20%28p%20%3D%200.07%29%20and%20systolic%20%28p%20%3D%200.01%29%20volumes%2C%20greater%20increase%20in%20ejection%20fraction%20%28p%20%3D%200.02%29%2C%20and%20had%20lowest%20event%20rates.%20Statistical%20models%20suggested%20several%20HF%20medications%20might%20lead%20to%20changes%20in%20both%20IGFBP7%20and%20mimecan%20values.%20The%20results%20suggest%20serial%20measurement%20of%20IGFBP7%20provides%20prognostic%20information%2C%20while%20changes%20in%20mimecan%20provide%20unique%20information%20regarding%20myocardial%20remodeling.%22%2C%22date%22%3A%22Mar%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12265-013-9522-8%22%2C%22ISSN%22%3A%221937-5395%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%2254MSBR4M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gaggin%20et%20al.%22%2C%22parsedDate%22%3A%222014-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGaggin%2C%20H.%20K.%2C%20Szymonifka%2C%20J.%2C%20%26lt%3Bstrong%26gt%3BBhardwaj%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20et%20al.%20%282014%29.%20Head-to-head%20comparison%20of%20serial%20soluble%20ST2%2C%20growth%20differentiation%20factor-15%2C%20and%20highly-sensitive%20troponin%20T%20measurements%20in%20patients%20with%20chronic%20heart%20failure.%20%26lt%3Bi%26gt%3BJACC%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%2065%26%23x2013%3B72.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jchf.2013.10.005%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jchf.2013.10.005%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Head-to-head%20comparison%20of%20serial%20soluble%20ST2%2C%20growth%20differentiation%20factor-15%2C%20and%20highly-sensitive%20troponin%20T%20measurements%20in%20patients%20with%20chronic%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%20K.%22%2C%22lastName%22%3A%22Gaggin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jackie%22%2C%22lastName%22%3A%22Szymonifka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%22%2C%22lastName%22%3A%22Belcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedetta%22%2C%22lastName%22%3A%22De%20Berardinis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shweta%22%2C%22lastName%22%3A%22Motiwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20L.%22%2C%22lastName%22%3A%22Januzzi%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20This%20analysis%20aimed%20to%20perform%20a%20head-to-head%20comparison%20of%203%20of%20the%20promising%20biomarkers%20of%20cardiovascular%20%28CV%29%20outcomes%20in%20heart%20failure%20%28HF%29-soluble%20ST2%20%28sST2%29%2C%20growth%20differentiation%20factor%20%28GDF%29-15%2C%20and%20highly-sensitive%20troponin%20T%20%28hsTnT%29-and%20to%20evaluate%20the%20role%20of%20serial%20measurement%20of%20these%20biomarkers%20in%20patients%20with%20chronic%20HF.%5CnBACKGROUND%3A%20sST2%2C%20GDF-15%2C%20and%20hsTnT%20are%20strongly%20associated%20with%20CV%20outcomes%20in%20HF.%5CnMETHODS%3A%20This%20post-hoc%20analysis%20used%20data%20from%20a%20study%20in%20which%20151%20patients%20with%20chronic%20HF%20due%20to%20left%20ventricular%20systolic%20dysfunction%20were%20followed%20up%20over%2010%20months.%20At%20each%20visit%2C%20N-terminal%20pro-B-type%20natriuretic%20peptide%20%28NT-proBNP%29%2C%20sST2%2C%20GDF-15%2C%20and%20hsTnT%20were%20measured%20and%20any%20major%20CV%20events%20were%20recorded.%5CnRESULTS%3A%20Baseline%20values%20of%20all%203%20novel%20biomarkers%20independently%20predicted%20total%20CV%20events%20even%20after%20adjusting%20for%20clinical%20and%20biochemical%20characteristics%2C%20including%20NT-proBNP%2C%20with%20the%20best%20model%20including%20all%203%20biomarkers%20%28p%20%26lt%3B%200.001%29.%20Adding%20serial%20measurement%20to%20the%20base%20model%20appeared%20to%20improve%20the%20model%26%23039%3Bs%20predictive%20ability%20%28with%20sST2%20showing%20the%20most%20promise%29%2C%20but%20it%20is%20not%20clear%20whether%20this%20addition%20is%20a%20unique%20contribution.%20However%2C%20when%20time-dependent%20factors%20were%20included%2C%20only%20sST2%20serial%20measurement%20independently%20added%20to%20the%20risk%20model%20%28odds%20ratio%3A%203.64%3B%2095%25%20confidence%20interval%3A%201.37%20to%209.67%3B%20p%20%3D%200.009%29%20and%20predicted%20reverse%20myocardial%20remodeling%20%28odds%20ratio%3A%201.22%3B%2095%25%20confidence%20interval%3A%201.04%20to%201.43%3B%20p%20%3D%200.01%29.%5CnCONCLUSIONS%3A%20In%20patients%20with%20chronic%20HF%2C%20baseline%20measurement%20of%20novel%20biomarkers%20added%20independent%20prognostic%20information%20to%20clinical%20variables%20and%20NT-proBNP.%20Only%20serial%20measurement%20of%20sST2%20appeared%20to%20add%20prognostic%20information%20to%20baseline%20concentrations%20and%20predicted%20change%20in%20left%20ventricular%20function.%20%28Use%20of%20NT-proBNP%20Testing%20to%20Guide%20Heart%20Failure%20Therapy%20in%20the%20Outpatient%20Setting%20%28PROTECT%29%5D%3B%20NCT00351390%29.%22%2C%22date%22%3A%22Feb%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jchf.2013.10.005%22%2C%22ISSN%22%3A%222213-1787%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22ZIJH7RNW%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gaggin%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGaggin%2C%20H.%20K.%2C%20%26lt%3Bstrong%26gt%3BBhardwaj%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%2C%20Belcher%2C%20A.%20M.%20et%20al.%20%282014%29.%20Design%2C%20methods%2C%20baseline%20characteristics%20and%20interim%20results%20of%20the%20Catheter%20Sampled%20Blood%20Archive%20in%20Cardiovascular%20Diseases%20%28CASABLANCA%29%20study.%20%26lt%3Bi%26gt%3BIJC%20Metabolic%20%26amp%3B%20Endocrine%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%2C%2011%26%23x2013%3B18.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcme.2014.08.005%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcme.2014.08.005%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Design%2C%20methods%2C%20baseline%20characteristics%20and%20interim%20results%20of%20the%20Catheter%20Sampled%20Blood%20Archive%20in%20Cardiovascular%20Diseases%20%28CASABLANCA%29%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%20K.%22%2C%22lastName%22%3A%22Gaggin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%20M.%22%2C%22lastName%22%3A%22Belcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shweta%20R.%22%2C%22lastName%22%3A%22Motiwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parul%20U.%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mandy%20L.%22%2C%22lastName%22%3A%22Simon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noreen%20P.%22%2C%22lastName%22%3A%22Kelly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20M.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Garasic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%20B.%22%2C%22lastName%22%3A%22Danik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%20H.%22%2C%22lastName%22%3A%22Schwamm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20E.%22%2C%22lastName%22%3A%22Gerszten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%20R.J.%22%2C%22lastName%22%3A%22van%20Kimmenade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20L.%22%2C%22lastName%22%3A%22Januzzi%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2211%5C%2F2014%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcme.2014.08.005%22%2C%22ISSN%22%3A%2222147624%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2214762414000279%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A37%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22HIZ4WRTM%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gaggin%20et%20al.%22%2C%22parsedDate%22%3A%222013-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGaggin%2C%20H.%20K.%2C%20Motiwala%2C%20S.%2C%20%26lt%3Bstrong%26gt%3BBhardwaj%26lt%3B%5C%2Fstrong%26gt%3B%2C%20A.%20et%20al.%20%282013%29.%20Soluble%20concentrations%20of%20the%20interleukin%20receptor%20family%20member%20ST2%20and%20%26%23x3B2%3B-blocker%20therapy%20in%20chronic%20heart%20failure.%20%26lt%3Bi%26gt%3BCirc%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%201206%26%23x2013%3B1213.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCHEARTFAILURE.113.000457%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCHEARTFAILURE.113.000457%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Soluble%20concentrations%20of%20the%20interleukin%20receptor%20family%20member%20ST2%20and%20%5Cu03b2-blocker%20therapy%20in%20chronic%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%20K.%22%2C%22lastName%22%3A%22Gaggin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shweta%22%2C%22lastName%22%3A%22Motiwala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%22%2C%22lastName%22%3A%22Bhardwaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%20A.%22%2C%22lastName%22%3A%22Parks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20L.%22%2C%22lastName%22%3A%22Januzzi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Concentrations%20of%20soluble%20%28s%29ST2%20predict%20prognosis%20in%20heart%20failure.%20We%20recently%20found%20changing%20doses%20of%20%5Cu03b2-blocker%20%28BB%29%20may%20affect%20sST2%20concentrations.%20It%20remains%20unclear%20whether%20sST2%20concentrations%20identify%20benefit%20of%20BB%20therapy%2C%20however.%5CnMETHODS%20AND%20RESULTS%3A%20A%20total%20of%20151%20subjects%20with%20heart%20failure%20attributable%20to%20left%20ventricular%20systolic%20dysfunction%20were%20examined%20in%20this%20post%20hoc%20analysis%3B%20%26gt%3B96%25%20were%20taking%20BB%20at%20enrollment.%20Medication%20regimen%20and%20sST2%20values%20were%20obtained%20during%2010%20months.%20Cardiovascular%20events%20were%20examined%20as%20a%20function%20of%20baseline%20sST2%20status%20%28low%20%5Cu226435%20versus%20high%20%26gt%3B35%20ng%5C%2FmL%29%20and%20final%20achieved%20BB%20dose%20%28high%20%5Cu226550%20versus%20low%20%26lt%3B50%20mg%20daily%20equivalent%20dose%20of%20metoprolol%20succinate%29.%20Patients%20with%20low%20sST2%20titrated%20to%20high-dose%20BB%20had%20the%20lowest%20cardiovascular%20event%20rate%20at%200.53%20events%20%28P%3D0.001%29%2C%20and%20lowest%20cumulative%20hazard%20%28P%3D0.003%29.%20Those%20with%20low%20sST2%5C%2Flow-dose%20BB%2C%20or%20high%20sST2%5C%2Fhigh-dose%20BB%20had%20intermediate%20outcomes%20%280.92%20and%201.19%20events%29.%20Patients%20with%20high%20sST2%20treated%20with%20low-dose%20BB%20had%20the%20highest%20cardiovascular%20event%20rate%20%282.08%20events%29%20and%20the%20highest%20cumulative%20hazard.%20Compared%20with%20low%20sST2%5C%2Fhigh-dose%20BB%2C%20those%20with%20high%20sST2%20treated%20with%20low-dose%20BB%20had%20an%20odds%20ratio%20of%206.77%20%28P%26lt%3B0.001%29%20for%20a%20cardiovascular%20event.%20Patients%20with%20low%20sST2%5C%2Flow-dose%20BB%20or%20high%20sST2%5C%2Fhigh-dose%20BB%20had%20intermediate%20odds%20ratios%20for%20cardiovascular%20events%20%28P%3D0.18%20and%200.02%29.%20Similar%20results%20were%20found%20for%20heart%20failure%20hospitalization%20and%20cardiovascular%20death.%5CnCONCLUSIONS%3A%20Although%20BB%20therapy%20exerted%20dose-related%20benefits%20across%20all%20study%20participants%2C%20sST2%20measurement%20identifies%20patients%20with%20chronic%20heart%20failure%20who%20may%20particularly%20benefit%20from%20higher%20BB%20doses.%5CnCLINICAL%20TRIAL%20REGISTRATION%3A%20URL%3A%20http%3A%5C%2F%5C%2Fwww.clinicaltrials.gov.%20Unique%20identifier%3A%20NCT00351390.%22%2C%22date%22%3A%22Nov%202013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCHEARTFAILURE.113.000457%22%2C%22ISSN%22%3A%221941-3297%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22G9NNXTPP%22%5D%2C%22dateModified%22%3A%222018-05-21T21%3A36%3A06Z%22%7D%7D%5D%7D
Gaggin, H. K., Liu, Y., Lyass, A. et al. (2017). Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography. Circulation 135, 116–127. https://doi.org/10.1161/CIRCULATIONAHA.116.023052.
Malik, S., MetroHealth Hospital, Case Western Reserve University, Cleveland, OH, Bhardwaj, A. et al. (2016). Advanced management options for massive and submassive pulmonary embolism. US Cardiology Review 10, 30. https://doi.org/10.15420/usc.2016.10.1.30.
Dunlap, M. E., Bhardwaj, A. and Hauptman, P. J. (2015). Autonomic modulation in heart failure: ready for prime time? Curr Cardiol Rep 17, 103. https://doi.org/10.1007/s11886-015-0652-2.
De Berardinis, B., Gaggin, H. K., Magrini, L. et al. (2015). Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. Clin Chem Lab Med 53, 613–621. https://doi.org/10.1515/cclm-2014-0191.
Bhardwaj, A. and Dunlap, M. E. (2015). Autonomic dysregulation as a therapeutic target for acute HF. Curr Treat Options Cardiovasc Med 17. https://doi.org/10.1007/s11936-015-0403-0.
Athappan, G., Gajulapalli, R. D., Sengodan, P. et al. (2014). Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol 63, 2101–2110. https://doi.org/10.1016/j.jacc.2014.02.540.
Motiwala, S. R., Szymonifka, J., Belcher, A. et al. (2014). Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling. J Cardiovasc Transl Res 7, 250–261. https://doi.org/10.1007/s12265-013-9522-8.
Gaggin, H. K., Szymonifka, J., Bhardwaj, A. et al. (2014). Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. JACC Heart Fail 2, 65–72. https://doi.org/10.1016/j.jchf.2013.10.005.
Gaggin, H. K., Bhardwaj, A., Belcher, A. M. et al. (2014). Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. IJC Metabolic & Endocrine 5, 11–18. https://doi.org/10.1016/j.ijcme.2014.08.005.
Gaggin, H. K., Motiwala, S., Bhardwaj, A. et al. (2013). Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure. Circ Heart Fail 6, 1206–1213. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000457.